Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter StudyKengo Ito, Mitsuru Ikeda, Michio Senda et al.|Journal of Alzheimer s Disease|2015Cited by 55
TAS-108, a Novel Oral Steroidal Antiestrogenic Agent, Is a Pure Antagonist on Estrogen Receptor α and a Partial Agonist on Estrogen Receptor β with Low Uterotrophic EffectYasuji Yamamoto, Tadafumi Terada|Clinical Cancer Research|2005Cited by 31